• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.

作者信息

Leanza L, Trentin L, Becker K A, Frezzato F, Zoratti M, Semenzato G, Gulbins E, Szabo I

出版信息

Leukemia. 2013 Aug;27(8):1782-5. doi: 10.1038/leu.2013.56. Epub 2013 Feb 21.

DOI:10.1038/leu.2013.56
PMID:23426166
Abstract
摘要

相似文献

1
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.氯法齐明、补骨脂素-4和PAP-1，钾通道Kv1.3的抑制剂，作为慢性淋巴细胞白血病的一种新型选择性治疗策略。
Leukemia. 2013 Aug;27(8):1782-5. doi: 10.1038/leu.2013.56. Epub 2013 Feb 21.
2
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.线粒体 Kv1.3 通道抑制剂诱导癌细胞的 Bax/Bak 非依赖性死亡。
EMBO Mol Med. 2012 Jul;4(7):577-93. doi: 10.1002/emmm.201200235. Epub 2012 Apr 11.
3
Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells.靶向钾通道Kv1.3可杀死胶质母细胞瘤细胞。
Neurosignals. 2017;25(1):26-38. doi: 10.1159/000480643. Epub 2017 Sep 1.
4
Psora-4, a Kv1.3 Blocker, Enhances Differentiation and Maturation in Neural Progenitor Cells.Psora-4，一种Kv1.3阻滞剂，可增强神经祖细胞的分化和成熟。
CNS Neurosci Ther. 2015 Jul;21(7):558-67. doi: 10.1111/cns.12402. Epub 2015 May 15.
5
Kv1.3 blockers ameliorate allergic contact dermatitis by preferentially suppressing effector memory T cells in a rat model.Kv1.3 阻断剂通过优先抑制效应记忆 T 细胞改善大鼠变应性接触性皮炎。
Clin Exp Dermatol. 2013 Dec;38(8):897-903. doi: 10.1111/ced.12097.
6
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo.直接靶向作用于线粒体离子通道选择性杀死体内肿瘤细胞。
Cancer Cell. 2017 Apr 10;31(4):516-531.e10. doi: 10.1016/j.ccell.2017.03.003.
7
Novel Kv1.3 blockers for immunosuppression: WO2012155199.新型 Kv1.3 通道阻滞剂的免疫抑制作用：WO2012155199。
Expert Opin Ther Pat. 2013 Nov;23(11):1511-6. doi: 10.1517/13543776.2013.831072. Epub 2013 Aug 23.
8
Targeting potassium channels Kv1.3 and KC a 3.1: routes to selective immunomodulators in autoimmune disorder treatment?靶向钾离子通道 Kv1.3 和 KC a 3.1：治疗自身免疫性疾病的选择性免疫调节剂途径？
Pharmacotherapy. 2013 May;33(5):515-28. doi: 10.1002/phar.1236. Epub 2013 Apr 5.
9
KCNE4-dependent modulation of Kv1.3 pharmacology.KCNE4 依赖性调节 Kv1.3 药理学。
Biochem Pharmacol. 2024 Aug;226:116368. doi: 10.1016/j.bcp.2024.116368. Epub 2024 Jun 14.
10
Pharmacological inhibition of Kv1.3 fails to modulate insulin sensitivity in diabetic mice or human insulin-sensitive tissues.在糖尿病小鼠或人类胰岛素敏感组织中，Kv1.3 的药理学抑制作用未能调节胰岛素敏感性。
Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E380-90. doi: 10.1152/ajpendo.00076.2011. Epub 2011 May 17.

引用本文的文献

1
Reliable high-PAP-1-loaded polymeric micelles for cancer therapy: preparation, characterization, and evaluation of anti-tumor efficacy.用于癌症治疗的可靠的高载药量PAP-1聚合物胶束：制备、表征及抗肿瘤疗效评估
Drug Deliv. 2025 Dec;32(1):2490269. doi: 10.1080/10717544.2025.2490269. Epub 2025 Apr 10.
2
Sodium, Potassium-Adenosine Triphosphatase as a Potential Target of the Anti-Tuberculosis Agents, Clofazimine and Bedaquiline.钠钾-腺苷三磷酸酶作为抗结核药物氯法齐明和贝达喹啉的潜在靶点
Int J Mol Sci. 2024 Dec 4;25(23):13022. doi: 10.3390/ijms252313022.
3
Expression of the ether-a-gò-gò-related gene 1 channel during B and T lymphocyte development: role in BCR and TCR signaling.
醚-α-戈戈相关基因 1 通道在 B 和 T 淋巴细胞发育过程中的表达：在 BCR 和 TCR 信号转导中的作用。
Front Immunol. 2023 Sep 8;14:1111471. doi: 10.3389/fimmu.2023.1111471. eCollection 2023.
4
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo.同时靶向线粒体 Kv1.3 和溶酶体酸性鞘磷脂酶增强体外和体内胰腺导管腺癌细胞的杀伤作用。
J Mol Med (Berl). 2023 Mar;101(3):295-310. doi: 10.1007/s00109-023-02290-y. Epub 2023 Feb 15.
5
Design of New Potent and Selective Thiophene-Based K1.3 Inhibitors and Their Potential for Anticancer Activity.新型强效选择性噻吩基K1.3抑制剂的设计及其抗癌活性潜力
Cancers (Basel). 2022 May 24;14(11):2595. doi: 10.3390/cancers14112595.
6
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma.线粒体Kv1.3通道作为多发性骨髓瘤的治疗靶点
Cancers (Basel). 2022 Apr 13;14(8):1955. doi: 10.3390/cancers14081955.
7
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.药物调节 Kv1.3 钾通道选择性地触发遗传 CLL 模型体内病理性 B 淋巴细胞凋亡。
J Exp Clin Cancer Res. 2022 Feb 16;41(1):64. doi: 10.1186/s13046-022-02249-w.
8
Alternative Targets for Modulators of Mitochondrial Potassium Channels.线粒体钾通道调节剂的替代靶标。
Molecules. 2022 Jan 4;27(1):299. doi: 10.3390/molecules27010299.
9
An understanding of mitochondria and its role in targeting nanocarriers for diagnosis and treatment of cancer.对线粒体及其在靶向纳米载体用于癌症诊断和治疗中的作用的理解。
Asian J Pharm Sci. 2021 Jul;16(4):397-418. doi: 10.1016/j.ajps.2020.10.002. Epub 2020 Nov 10.
10
Potassium and Chloride Ion Channels in Cancer: A Novel Paradigm for Cancer Therapeutics.癌症中的钾离子和氯离子通道：癌症治疗的新范式
Rev Physiol Biochem Pharmacol. 2022;183:135-155. doi: 10.1007/112_2021_62.